Free Trial

3 Underperforming Nasdaq 100 Stocks Worth a Closer Look

Key Points

  • The strategy of rotating to the Nasdaq’s biggest laggards is far from foolproof, but it makes good sense.
  • Despite being down more than 40% year-to-date, analysts still have faith in Enphase Energy.
  • Moderna’s mRNA pipeline includes 45 vaccine and therapeutic candidates.
  • The company also announced a partnership with IBM to explore the use of generative AI and quantum computing in mRNA science.
  • With a consensus price target that implies nearly 80% upside, Zscaler could be one of the Nasdaq-100’s biggest comeback stories of 2023-2024.
  • MarketBeat previews the top five stocks to own by June 1st.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Enphase Energy Right Now?

Before you consider Enphase Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enphase Energy wasn't on the list.

While Enphase Energy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enphase Energy (ENPH)
4.8901 of 5 stars
$50.80+3.6%N/A68.65Hold$70.54
Moderna (MRNA)
4.4336 of 5 stars
$24.25-0.5%N/A-2.61Hold$53.95
Zscaler (ZS)
3.6098 of 5 stars
$233.060.0%N/A-932.24Moderate Buy$236.66
Verizon Communications (VZ)
4.7313 of 5 stars
$43.65+0.1%6.21%10.54Moderate Buy$47.41
Intel (INTC)
2.7954 of 5 stars
$21.44+2.1%2.33%-4.89Reduce$22.23
PDD (PDD)
4.9169 of 5 stars
$109.65-0.2%N/A10.71Moderate Buy$169.91
T-Mobile US (TMUS)
4.622 of 5 stars
$243.81-1.5%1.44%25.21Moderate Buy$257.68
Activision Blizzard (ATVI)
0.7289 of 5 stars
$94.42flat1.05%34.59N/AN/A
Meta Platforms (META)
4.0591 of 5 stars
$592.49-0.9%0.35%24.77Moderate Buy$696.45
Tesla (TSLA)
4.1924 of 5 stars
$298.05+4.6%N/A146.10Hold$287.46
Align Technology (ALGN)
4.4779 of 5 stars
$181.81+0.5%N/A32.41Moderate Buy$241.25
Merck & Co., Inc. (MRK)
5 of 5 stars
$75.88-2.3%4.27%11.27Moderate Buy$111.13
International Business Machines (IBM)
4.3318 of 5 stars
$249.32-1.9%2.70%38.90Moderate Buy$248.50
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Related Videos

Markets in Rally Mode: Will Earnings Keep It Going?
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines